Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4/A Grant or award Chief Executive Officer acquired 519,328 shares (grant or award)
  2. 4/A Insider Changes in Ownership
  3. 4 Grant or award Director acquired 35,360 shares (grant or award)
  4. 4 Grant or award Director acquired 35,360 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 35,360 shares (grant or award)
  7. 4 Grant or award Director acquired 35,360 shares (grant or award)
  8. 4 Grant or award Director acquired 35,360 shares (grant or award)
  9. 4/A Grant or award Director acquired 35,360 shares (grant or award)
  10. 4 Grant or award Director acquired 35,360 shares (grant or award)
  11. 4 Grant or award Director acquired 35,360 shares (grant or award)
  12. 4 Grant or award Director acquired 35,360 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Director acquired 5,890 shares (grant or award)
  15. 4 Grant or award Director acquired 3,122 shares (grant or award)
  16. 4 Grant or award Director acquired 2,945 shares (grant or award)
  17. 4 Grant or award Director acquired 647 shares (grant or award)
  18. 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,188 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 116,982 shares (to pay taxes)
  20. 4 Planned sale EVP, General Counsel sold 6,313 shares at $9.80 ($61,867)

Page 6 of 61 · 1,214 filings